The development of the Chemotherapy Symptom Assessment Scale (C-SAS): a scale for the routine clinical assessment of the symptom experiences of patients receiving cytotoxic chemotherapy.
The management of symptoms experienced by patients receiving cytotoxic chemotherapy influences quality of life during treatment. Symptom management may be improved through a structured approach to symptom assessment. This paper describes the development of the Chemotherapy Symptom Assessment Scale (C-SAS), a 24-item scale designed for the routine assessment of symptoms experienced by patients receiving cytotoxic chemotherapy. The scale development process focused both upon the psychometric properties and the clinical usefulness of the scale. Patients and health professionals played a significant role in item selection and scale design in order to maximise the clinical utility of the C-SAS.
Brown
V
V
Research and Development Department, Worthing and Southlands Hospitals NHS Trust, Lyndhurst Road, Worthing, West Sussex BN11 2DH, UK. vivienne.brown@wash-tr.sthames.nhs.uk
Sitzia
J
J
Richardson
A
A
Hughes
J
J
Hannon
H
H
Oakley
C
C
D000970:Antineoplastic Agents / Q000009:adverse effects*; D001291:Attitude of Health Personnel; D001294:Attitude to Health; D016903:Drug Monitoring / Q000451:nursing*; D005163:Factor Analysis, Statistical; D005260:Female; D006801:Humans; D008297:Male; D008875:Middle Aged; D009369:Neoplasms / Q000188:drug therapy / Q000451:nursing / Q000523:psychology; D009730:Nursing Assessment / Q000379:methods / Q000592:standards*; D015403:Nursing Evaluation Research; D009859:Oncology Nursing; D011594:Psychometrics; D011788:Quality of Life
D000970:Antineoplastic Agents